Logo
x

Search

Subscribe Now

BioLineRx

BioLineRx Reports First Patient Dosing with Motixafortide in P-II Study for the Treatment of Pancreatic Cancer (PDAC)

BioLineRx Reports First Patient Dosing with Motixafortide in P-II Study for the Treatment of Pancreatic Cancer (PDAC)

  • February 29, 2024
Insights+: The US FDA New Drug Approvals in September 2023

Insights+: The US FDA New Drug Approvals in September 2023

  • October 19, 2023
BioLineRx’s Aphexda (motixafortide) + Filgrastim Receives the US FDA’s Approval for Multiple Myeloma

BioLineRx’s Aphexda (motixafortide) + Filgrastim Receives the US FDA’s Approval for Multiple Myeloma

  • September 12, 2023
Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

  • November 26, 2020
PharmaShots Weekly Snapshot (November 04-08, 2019)

PharmaShots Weekly Snapshot (November 04-08, 2019)

  • November 11, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.